Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy

Published:2018-01-15 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Bernal-Estévez David A.,García Oscar,Sánchez Ramiro,Parra-López Carlos A.

Funder

Dirección de Investigación, Universidad Nacional de Colombia

Fundación Salud de los Andes, Universidad Nacional de Colombia y Colciencias

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-017-3982-1.pdf

Reference51 articles.

1. Kepp O, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014;3(9):e955691.

2. Vacchelli E, et al. Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer. Oncoimmunology. 2012;1(3):271–8.

3. Ladoire S, et al. In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival. J Pathol. 2011;224(3):389–400.

4. Angell H, Galon J. From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer. Curr Opin Immunol. 2013;25(2):261–7.

5. Galon J, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960–4.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products;Phytomedicine;2024-09

2. Effect of neoadjuvant chemotherapy on tumor immune infiltration in breast cancer patients: Systematic review and meta-analysis;PLOS ONE;2023-04-27

3. Neoadjuvant chemotherapy modulates exhaustion of T cells in breast cancer patients;PLOS ONE;2023-02-10

4. The application basis of immuno-checkpoint inhibitors combined with chemotherapy in cancer treatment;Frontiers in Immunology;2023-01-10

5. Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice;Frontiers in Immunology;2022-01-05